Major reforms are set to transform Medicare Part D in 2026, primarily driven by the Inflation Reduction Act. This article delves into the crucial changes, particularly the new out-of-pocket spending limit, and how these will profoundly impact prescription drug costs and access for millions of senior beneficiaries.